A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis

(2018) Timothy Aksamit et al.   EUROPEAN RESPIRATORY JOURNAL

Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial

(2018) Beatriz Herrero-Cortina et al.   Journal of Aerosol Medicine and Pulmonary Drug Delivery

Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)?

(2018) Shaun Treweek et al.   Trials

Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention

(2018) Scott C. Bell et al.   RESPIROLOGY

Non-cystic fibrosis bronchiectasis in the elderly: current perspectives

(2018) Tom M Quinn et al.   Clinical Interventions in Aging

Updated BTS Adult Bronchiectasis Guideline 2018: a multidisciplinary approach to comprehensive care

(2018) Adam T Hill et al.   THORAX

Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

(2017) Adam T. Hill et al.   EUROPEAN RESPIRATORY JOURNAL

European Respiratory Society guidelines for the management of adult bronchiectasis

(2017) Eva Polverino et al.   EUROPEAN RESPIRATORY JOURNAL

Pragmatic Trials

(2016) Ian Ford et al.   NEW ENGLAND JOURNAL OF MEDICINE

The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis

(2016) Arietta Spinou et al.   THORAX

Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study

(2015) Jennifer K. Quint et al.   EUROPEAN RESPIRATORY JOURNAL

Predictors of adherence to treatment in bronchiectasis

(2015) Amanda R. McCullough et al.   RESPIRATORY MEDICINE

Reclaiming the name ‘bronchiectasis’

(2015) James D Chalmers et al.   THORAX

Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores

(2014) Alexandra L Quittner et al.   THORAX

The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis

(2012) Caroline H.H. Nicolson et al.   RESPIRATORY MEDICINE

Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis

(2011) M. E. Roberts et al.   INTERNAL MEDICINE JOURNAL

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

(2011) M. Herdman et al.   QUALITY OF LIFE RESEARCH

Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis

(2011) Fiona Kellett et al.   RESPIRATORY MEDICINE

Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis

(2010) James D. Finklea et al.   RESPIRATORY MEDICINE

British Thoracic Society guideline for non-CFbronchiectasis

(2010) M. C. Pasteur et al.   THORAX

Exacerbations in cystic fibrosis: 4 {middle dot} Non-cystic fibrosis bronchiectasis

(2008) A B Chang et al.   THORAX